ConductScience.org, home

Disease · HP_0000225

Gingival bleeding

6 sourcesdiseases-2026-09-18-0.1.0

Download JSON
Cite this record

ConductScience Library. Gingival bleeding. Diseases, record HP_0000225. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/HP_0000225

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name
Gingival bleeding
Open Targets ID
HP_0000225
Other names
Bleeding gums, Gingival haemorrhage, Gingival hemorrhage, Gingivorrhagia
Highest stage of its drugs
Approval, for 1 of its 6 drugs, from DailyMed

Source Open Targets

Drugs6

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

DrugChEMBL IDTypeOpen Targets' stageStage reported byReportsOf them trialsTrials shown hereSource
STANNOUS FLUORIDECHEMBL1909079Small moleculeApprovalDailyMed100Drugs and targets
POLIGLUSAMCHEMBL2108133Small moleculePhase 3ClinicalTrials.gov111Drugs and targets
SODIUM BICARBONATECHEMBL1353Small moleculePhase 2ClinicalTrials.gov222Drugs and targets
SODIUM FLUORIDECHEMBL1528Small moleculePhase 2ClinicalTrials.gov222Drugs and targets
CHLORHEXIDINECHEMBL790Small moleculeUnknownClinicalTrials.gov222Drugs and targets
GARLICCHEMBL2108463UnknownClinicalTrials.gov111Drugs and targets

Targets0

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

None in this release.

Trials5

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.

TrialTitlePhaseParticipantsResults first postedConditionsDrugsLinked bySource
NCT02207907To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate ToothpastePhase 22472017-02-17Oral HygieneSODIUM BICARBONATE, SODIUM FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT02207400To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant OrganismsPhase 22462016-07-26Oral HygieneSODIUM BICARBONATE, SODIUM FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT07499115Efficacy of a Toothpaste in Reducing Plaque, Gingivitis, and Gingival BleedingPhase 390Plaque, Dental, GingivitisPOLIGLUSAMIts record names the diseaseClinicalTrials.gov
NCT03166163Evaluation of Bleeding on Brushing Using Neem Extract Mouthwash Versus Chlorhexidine MouthwashNot applicable86Gingival BleedingCHLORHEXIDINEIts record names the diseaseClinicalTrials.gov
NCT03105960Garlic With Lime Juice and Chlorhexidine MouthwashNot applicable36Gingival BleedingCHLORHEXIDINE, GARLICIts record names the diseaseClinicalTrials.gov

Comparisons in its trials2

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Sodium Bicarbonate Dentrifice vs 0% Sodium Bicarbonate Dentrifice: serious adverse events0 of 1240 of 123247NCT02207907Trial comparisons
Sodium Bicarbonate and Sodium Fluoride Dentifrice vs Sodium Fluoride Dentifrice: serious adverse events0 of 1230 of 123246NCT02207400Trial comparisons

Papers from its trials1

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMIDListed asTrials listing it
29758155DERIVED1

Source PubMed

Data dates

The date of each source this release read.

Open Targets
2026-09-18
Open Targets
Drug links and their checks, from Drugs and targets
2026-09-18
Drugs and targets
ClinicalTrials.gov, from Trials
2026-11-12
Trials
Comparisons, from Trial comparisons
2026-03-23
Trial comparisons
PubMed, for the checks
2026-11-06
PubMed
MeSH, for the checks
2026-11-10
MeSH

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/HP_0000225

GET https://conductscience.org/api/diseases/v1/HP_0000225/drugs